Next-generation NovaSure device for endometrial ablation: assessing ease-of-use among physicians

To compare physician assessment of the next-generation NovaSure(®) device to the original NovaSure device.

Prospective open-label, unblinded survey utilizing Likert scales.

Community-based obstetrician and gynecology practices.

There were 270 evaluations completed by 168 physicians for women undergoing endometrial ablation with the next-generation NovaSure device compared to the previous model.

Physician survey across multiple community-based obstetrician and gynecology practices.

In general, 53.7% of women had a normal uterus, with an average cavity length of 5.3 cm ± 0.9 cm, and 44.7% of women had a normal cervix. Overall, 98.7% of physicians agreed or strongly agreed that they were satisfied with the performance of the next-generation NovaSure device compared with the previous device. Additionally, 89% of physicians rated the next-generation NovaSure device as superior to the previous device. The best rated features were the SureFit™ Cervical Seal, Smooth Access™ Tips, and the thumb-pusher. No adverse events were reported in this study.

Community-based physicians rated the next-generation NovaSure device as superior to the previous model in a general population of women.